20-50948650-G-C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_003859.3(DPM1):c.274C>G(p.Arg92Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R92Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_003859.3 missense
Scores
Clinical Significance
Conservation
Publications
- congenital disorder of glycosylation type 1EInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, G2P, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPM1 | NM_003859.3 | c.274C>G | p.Arg92Gly | missense_variant | Exon 3 of 9 | ENST00000371588.10 | NP_003850.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152040Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251480 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461620Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727120 show subpopulations
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74236 show subpopulations
ClinVar
Submissions by phenotype
Congenital disorder of glycosylation type 1E Pathogenic:2
- -
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 92 of the DPM1 protein (p.Arg92Gly). This variant is present in population databases (rs121908583, gnomAD 0.006%). This missense change has been observed in individual(s) with congenital disorder of glycosylation (PMID: 10642597, 10642602, 27481510). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6296). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects DPM1 function (PMID: 10642602). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 31003021, 21029365, 23856421, 21315133, 10642597, 27481510, 35279850, 15669674, 10642602) -
DPM1-related disorder Pathogenic:1
The DPM1 c.274C>G variant is predicted to result in the amino acid substitution p.Arg92Gly. This variant has been reported in the compound heterozygous and homozygous states in individuals with congenital disorder of glycosylation 1e, and both functional studies and segregation data support its pathogenicity (Kim et al. 2000. PubMed ID: 10642597; Bursle et al. 2016. PubMed ID: 27481510; Imbach et al. 2000. PubMed ID: 10642602). This variant is reported in 0.0046% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at